Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Res Bull ; 56(3-4): 285-97, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11719263

RESUMO

Spinobulbar muscular atrophy (SBMA) is a neurodegenerative disease caused by the expansion of the polyglutamine (polyGln) tract in the human androgen receptor (hAR). One mechanism by which polyGln-expanded proteins are believed to cause neuronotoxicity is through aberrant interaction(s) with, and possible sequestration of, critical cellular protein(s). Our goal was to confirm and further characterize the interaction between hAR and cytochrome c oxidase subunit Vb (COXVb), a nuclear-encoded mitochondrial protein. We initially isolated COXVb as an AR-interacting protein in a yeast two-hybrid screen to identify candidate proteins that interacted with normal and polyGln-expanded AR. Using the mammalian two-hybrid system, we confirm that COXVb interacts with normal and mutant AR and demonstrated that the COXVb-normal AR interaction is stimulated by heat shock protein 70. In addition, blue fluorescent protein-tagged AR specifically co-localized with cytoplasmic aggregates formed by green fluorescent protein-labeled polyGln-expanded AR in androgen-treated cells. Mitochondrial dysfunction may precede neuropathological findings in polyGln-expanded disorders and may thus represent an early event in neuronotoxicity. Interaction of COXVb and hAR, with subsequent sequestration of COXVb, may provide a mechanism for putative mitochondrial dysfunction in SBMA.


Assuntos
Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Transtornos Musculares Atróficos/genética , Transtornos Musculares Atróficos/metabolismo , Receptores Androgênicos/genética , Receptores Androgênicos/metabolismo , Animais , Células COS , Complexo IV da Cadeia de Transporte de Elétrons/genética , Genes Reporter , Proteínas de Fluorescência Verde , Proteínas de Choque Térmico HSP70/metabolismo , Hormônios/farmacologia , Humanos , Indicadores e Reagentes/metabolismo , Proteínas Luminescentes/genética , Mamíferos , Mitocôndrias/metabolismo , Degeneração Neural/genética , Degeneração Neural/metabolismo , Peptídeos/genética , Proteínas Recombinantes de Fusão/genética , Expansão das Repetições de Trinucleotídeos , Técnicas do Sistema de Duplo-Híbrido
2.
Dev Dyn ; 222(1): 52-70, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11507769

RESUMO

The formation of a secondary ossification center in the cartilaginous epiphysis of long bones requires the excavation of canals and marrow space and, therefore, the resorption of cartilage. On the assumption that its resorption requires the lysis of the major cartilage component aggrecan, it was noted that the core protein may be cleaved in vitro by proteinases from two subfamilies: matrix metalloproteinases (MMPs) and aggrecanases. Such cleavage results in aggrecan being replaced by a fragment of itself referred to as a "G1-fragment." To find out if this cleavage occurs in the developing epiphysis of the rat tibia, the approach has been to localize the G1 fragments. For this purpose two neoepitope antisera were applied, one capable of recognizing the MMP-generated G1-fragment that bears the C-terminus ...FVDIPEN341 and the other capable of recognizing the aggrecanase-generated G1-fragment that carries the C-terminus ...NITEGE373. With the aid of these antisera, we report here that aggrecan cleavage is localized to newly developed sites of erosion. Thus, at 6 days of age, canals allowing the entry of capillaries are dug out from the surface of the epiphysis in a radial direction (stage I), whereas immunostaining indicative of aggrecan cleavage by MMPs appears at the blind end of each canal. The next day, the canal blind ends fuse to create a marrow space in the epiphysis (stage II), whereas immunostaining produced by MMPs occurs along the walls of this space. By 9 days, clusters of hypertrophic chondrocytes are scattered along the marrow space wall to initiate the formation of the secondary ossification center (stage III), where the resorption sites are unreactive to either antiserum. From the 9th to the 21st day, the center keeps on enlarging and, as the distal wall of the marrow space recedes, it is intensely immunostained with both antisera indicating that both MMPs and aggrecanases are involved in this resorption. We conclude, that both enzyme subfamilies contribute to the lysis of aggrecan. However, the results suggest that the respective subfamilies target different sites and even stages of development in the tissue, suggesting some diversity in the mode of aggrecan lysis during the excavation of a secondary ossification center.


Assuntos
Reabsorção Óssea , Cartilagem/metabolismo , Proteínas da Matriz Extracelular , Proteoglicanas/metabolismo , Tíbia/enzimologia , Agrecanas , Animais , Western Blotting , Medula Óssea/metabolismo , Condrócitos/metabolismo , Relação Dose-Resposta a Droga , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Epífises , Guanidina/metabolismo , Immunoblotting , Imunoglobulina G/metabolismo , Imuno-Histoquímica , Lectinas Tipo C , Masculino , Metaloproteinases da Matriz/metabolismo , Microscopia Eletrônica , Microscopia Imunoeletrônica , Modelos Biológicos , Peptídeos/química , Ratos , Ratos Sprague-Dawley , Tíbia/embriologia , Fatores de Tempo
3.
Dev Dyn ; 222(1): 71-88, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11507770

RESUMO

In the transformation of the cartilaginous epiphysis into bone, the first indication of change in the surfaces destined for resorption is the cleavage of aggrecan core protein by unidentified matrix metalloproteinases (MMPs) (Lee et al., this issue). In cartilage areas undergoing resorption, the cleavage leaves as superficial, 6-microm-thick band of matrix, referred to as "pre-resorptive layer." This layer harbors G1-fragments of the aggrecan core protein within a framework of collagen-rich fibrils exhibiting various stages of degeneration. Investigation of this layer in every resorption area by gelatin histozymography and TIMP-2 histochemistry demonstrates the presence of an MMP whose histozymographic activity is inhibited by such a low dose of the inhibitor CT1746 as to identify it as gelatinase A or B. Attempts at blocking the histozymographic reactions with neutralizing antibodies capable of inhibiting either gelatinase A or B reveals that only those against gelatinase B do so. Immunostaining of sections with anti-gelatinase B IgG confirms the presence of gelatinase B in every pre-resorptive layer, that is, at the blind end of excavated canals (stage I; 6-day-old rats), at sites along the walls of the forming marrow space (stage II; 7days), at sites within the walls of this space as it becomes the ossification center (stage III; 9 days) and along the wall of the maturing center (stage IV; 10-21 days). We also report the presence of collagenase-3 in precisely the same sites, possibly as active enzyme, but this remains to be proven. Because the results reveal that collagenase-3 is present beside gelatinase B in every pre-resorptive layer and, because these sites exhibit various signs of degradation including fibrillar debris, reduction in fibril number, or overt loss, we propose that gelatinase B and collagenase-3 mediate the lysis of this pre-resorptive layer-most likely through a cooperative attack leading to the disintegration of the collagen fibril framework.


Assuntos
Reabsorção Óssea , Cartilagem/enzimologia , Cartilagem/fisiologia , Colágeno/metabolismo , Colagenases/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Animais , Biotinilação , Osso e Ossos/embriologia , Osso e Ossos/ultraestrutura , Eletroforese em Gel de Poliacrilamida , Inibidores Enzimáticos/farmacologia , Epífises/metabolismo , Gelatina/metabolismo , Imunoglobulina G/metabolismo , Imuno-Histoquímica , Masculino , Metaloproteinase 13 da Matriz , Inibidores de Metaloproteinases de Matriz , Metaloproteinases da Matriz/metabolismo , Microscopia Eletrônica , Microscopia Imunoeletrônica , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Inibidor Tecidual de Metaloproteinase-1/farmacologia , Inibidor Tecidual de Metaloproteinase-2/metabolismo , Inibidor Tecidual de Metaloproteinase-2/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...